An observational study of pro- and anti-angiogenic factors in hypertensive disorders of pregnancy in women of African ancestry
- 22 July 2022
- journal article
- research article
- Published by Taylor & Francis in Journal of Obstetrics and Gynaecology
- Vol. 42 (7) , 2698-2703
Abstract
Hypertensive disorders in pregnancy (HDPs) are the leading cause of maternal and perinatal deaths worldwide. Despite the widely reported multisystemic pathophysiology of pre-eclampsia and other HDPs, it is unknown whether these disorders represent a continuum or separate entities making clinical diagnosis a challenge. This study aimed to investigate angiogenic, metabolic and immunoregulatory specific profiles of hypertensive and gestationally matched normotensive pregnancies. A total of 200 pregnancies from a regional hospital in South Africa, via convenience sampling, were quantitatively analysed for circulating sFlt-1; PlGF; VEGF; sENG; PAPP-A; PP13; ADAMTS 12; TGF-β1 in maternal serum samples using ELISA technique. Serum protein markers TGF-β1, sENG and PAPP-A were significantly increased (p < .05) in early-onset pre-eclampsia vs. NG1 groups. sFlt-1 was significantly higher in late-onset pre-eclampsia vs NG2 groups. The GH group showed a significant increase in TGF-β1 and PAPP-A vs. NG1 counterpart. ADAMTS12 and sENG were significantly lower in gestational hypertension vs. early-onset pre-eclampsia. No significant differences were seen in PlGF, VEGF and PP13 levels across the groups. These changes show the HDP spectrum has distinct characteristics on the angiogenic profile. Based on these results, further validation of diagnostic and prognostic biomarkers of pre-eclampsia and gestational hypertension is warranted.Keywords
Funding Information
- National Research Foundation (TTK180410319237)
This publication has 26 references indexed in Scilit:
- Low maternal serum pregnancy-associated plasma protein-A as a risk factor of preeclampsiaSingapore Medical Journal, 2018
- Comparison of risk factors and outcomes of gestational hypertension and pre-eclampsiaPLOS ONE, 2017
- The role of ADAMTS genes in preeclampsiaJournal of Turkish Society of Obstetric and Gynecology, 2016
- Predictive value of miR-210 as a novel biomarker for pre-eclampsia: a systematic review protocolBMJ Open, 2016
- Angiogenic Factors in PreeclampsiaHypertension, 2016
- Pre-eclampsia: its pathogenesis and pathophysiolgyCardioVascular Journal of Africa, 2016
- ADAM12 and PAPP-A: Candidate regulators of trophoblast invasion and first trimester markers of healthy trophoblastsCell Adhesion & Migration, 2016
- Circulating ADAMTS-12 levels in early- and late-onset severe preeclampsiaMedicine Science | International Medical Journal, 2016
- Placental Disease and the Maternal Syndrome of Preeclampsia: Missing Links?Current Hypertension Reports, 2013
- First trimester PAPP-A levels correlate with sFlt-1 levels longitudinally in pregnant women with and without preeclampsiaBMC Pregnancy and Childbirth, 2013